We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

46 hedge funds and large institutions have $10.4M invested in EnteroMedics Inc. in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 11

10% less funds holding

Funds holding: 5146 (-5)

17% less capital invested

Capital invested by funds: $12.5M → $10.4M (-$2.14M)

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

83% less call options, than puts

Call options by funds: $16K | Put options by funds: $93K

Holders
46
Holders Change
-5
Holders Change %
-9.8%
% of All Funds
1.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
10
Reduced
11
Closed
12
Calls
$16K
Puts
$93K
Net Calls
-$77K
Net Calls Change
+$76K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
51
UBS Group
Switzerland
-$14K -15 Closed
ST
52
Spot Trading
Illinois
-$13K -14 Closed
Bank of America
53
Bank of America
North Carolina
-$5K -5 Closed
Citigroup
54
Citigroup
New York
-$5K -5 Closed
Group One Trading
55
Group One Trading
Illinois
-$4.6K -4 Closed
Creative Planning
56
Creative Planning
Kansas
-$1K -1 Closed
TRCT
57
Tower Research Capital (TRC)
New York
-$1K -1 Closed
PRCM
58
Pine River Capital Management
Minnesota
+$52.9K +46 +418%

ETRM Hedge Fund Activity: Q2 2015 in Review

46 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q2 2015, worth a combined $10.4M — down 17% from $12.5M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ETRM and 7 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 10 added.

The largest buyer was Tenor Capital Management, opening a new position worth an estimated $3.34M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.52M.

  • 46 institutional investors held EnteroMedics Inc. (ETRM) as of Q2 2015, down from 51 in Q1 2015.
  • Funds reported $10.4M of EnteroMedics Inc. stock for Q2 2015, down 17% quarter-over-quarter.
  • 7 funds opened new EnteroMedics Inc. positions in Q2 2015 and 12 closed out, a net change of -5 holders.
  • The largest EnteroMedics Inc. buyer in Q2 2015 was Tenor Capital Management, an estimated $3.34M added.
  • The largest EnteroMedics Inc. seller in Q2 2015 was T. Rowe Price Associates, an estimated $2.52M sold.

Based on aggregated 13F filings for Q2 2015.